JK
Jeff E. Knight (Chief Operating Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Crinetics Pharmaceuticals, Inc. (CRNX). The largest single filing was $3.4M of CRNX (85,163 sh × $40.10, as filed), executed Apr 8. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$3.8M
shares × price, as filed
Last traded
Apr 8
Filed Apr 10
Median ADV $326.9M across their filed names
Open performance→Volume by month
Buys $0
Sells $4.0M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
CRNXRecent filings
CRNXSALE
Crinetics Pharmaceuticals, Inc.
View filing →
$3.4M85,163 sh × $40.10
Exec Apr 8
Filed Apr 10 · 5:30 PM ET CRNXSALE Crinetics Pharmaceuticals, Inc. View filing → $370K
9,911 sh across 2 lots
Exec Mar 16
Filed Mar 18 · 5:30 PM ET CRNXSALE Crinetics Pharmaceuticals, Inc. View filing → $232K
6,801 sh × $34.17
Exec Mar 19 2025
Filed Mar 21 2025 · 5:30 PM ET